Related Experiment Video

Updated: Sep 26, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Panipenem/betamipron

Karen L Goa1, Stuart Noble

  • 1Adis International Limited, Auckland, New Zealand. demail@adis.co.nz

Drugs
|April 8, 2003
PubMed

Insights

Panipenem/betamipron is an effective parenteral carbapenem antibiotic for various infections, demonstrating good clinical and bacteriological outcomes. This combination therapy showed favorable tolerability with minimal adverse events in diverse patient populations.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Panipenem is a parenteral carbapenem antibiotic with broad-spectrum activity against Gram-negative and Gram-positive bacteria.
  • It is administered with betamipron to prevent nephrotoxicity by inhibiting renal tubule uptake.
  • The combination targets infections caused by beta-lactamase-producing bacteria and Streptococcus pneumoniae.

Purpose of the Study:

  • To evaluate the clinical and bacteriological efficacy of panipenem/betamipron.
  • To assess the safety and tolerability of panipenem/betamipron in various patient groups.
  • To compare panipenem/betamipron with other antibiotics in specific patient populations.

Main Methods:

  • Large, randomized clinical trials in adults with respiratory and urinary tract infections.
  • Non-comparative trials in adults with surgical/gynecological infections and pediatric patients.
  • Small trials in elderly patients comparing efficacy against piperacillin and ofloxacin.

Main Results:

  • Panipenem/betamipron demonstrated good clinical and bacteriological efficacy, comparable to imipenem/cilastatin.
  • Effective in treating respiratory, urinary, surgical, and gynecological infections in adults.
  • Showed efficacy in pediatric patients and elderly patients with urinary and respiratory tract infections.

Conclusions:

  • Panipenem/betamipron is a clinically effective and well-tolerated treatment option for a wide range of bacterial infections.
  • Its efficacy is comparable to established treatments like imipenem/cilastatin.
  • The combination therapy presents a favorable safety profile with generally mild adverse events.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...